Archives

One of the key roles of the visiting pharmacist is to make sure that medicines are used safely and appropriately. This involves monitoring the prescription charts to ensure legal requirements are [...]

All hospitals and other healthcare settings must have controlled drugs (CD) registers to record their stocks of CDs in order to comply with regulations. There are a variety of controlled drugs [...]

The MHRA proposes to regulate e-cigarettes following their widespread use and the current lack of safety or quality monitoring. The will be licensed as medicines in the same way as [...]

There has been a report in the national media of a fatality caused by clozapine-induced severe constipation, which occurred to an inpatient at a hospital in the UK. All patients prescribed [...]

It is a regulatory requirement of the Care Quality Commission’s Essential Standards of Quality and Safety (Outcome 9) that “staff handling medicines have the competency and skills [...]

Social anxiety disorder (or social phobia) is very common, with an estimated lifetime prevalence of 12%. Co-morbidity with other mental health problems such as depression, substance misuse and [...]

Last year, Ashtons was involved in a safety study for the MHRA, which involved monitoring the side effects of different formulations of quetiapine tablets. This year, we have been asked to carry [...]

Nalmefene reduces the amount of alcohol that a heavy drinker will consume. Reducing alcohol intake is a positive step towards abstinence, and nalmefene should be used in conjunction with [...]

July 2013 – Lisdexamfetamine is indicated for ADHD (attention deficit/hyperactivity disorder) in children over 6 years, where clinical response to methylphenidate has been inadequate. [...]